• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 8, 2017

Trends in Obesity and Diabetes

Author(s):

Jeannette Y. Wick, RPh, MBA, FASCP

Obesity-related diabetes is transforming into a global health crisis that is no longer limited to developed countries.

Parallel trends in diabetes and obesity have led clinicians to think about these metabolic disorders as 2 parts of a whole, calling the umbrella condition “diabesity” (obesity-related diabetes). Diabesity is quickly transforming into a global health crisis that is no longer limited to developed countries.

Existing guidelines do not address optimal medical management of diabesity. A review article published in Current Diabetes Reports discusses current therapy options.

Diabesity’s pathogenesis is complex and involves neurochemical, genetic, inflammatory, and lifestyle factors. To best treat these patients, pharmacists must balance adequate glycemic control with the risk of further weight gain.

The authors’ recommendations include the following:

■ Clinicians should reserve insulin—which is anabolic in nature—for episodes requiring rapid glycemic control, or when diabesity is refractory.

■ Metformin is the first-line option for all patients with diabesity. It has a moderate weight benefit, and is associated with improvements in comorbid conditions.

■ Glucagon-like peptide-1 receptor agonists have the greatest weight loss benefit and offer improvements in comorbid conditions. Despite initial concerns of pancreatitis, high-dose liraglutide (3 mg daily, now FDA approved) is safe and can help some patients achieve weight loss of more than 15%.

■ Dipeptidyl peptidase-4 inhibitors and sodium glucose co-transporter 2 inhibitors are effective oral agents for reducing HbA1c without weight gain.

■ Clinicians should avoid thiazolidinedione and sulfonylureas as first line due to associated weight gain. They may be useful as adjunct in refractory patients when combined with weight loss interventions.

■ Insulin-metformin therapy has insulin-sparing effect, and is associated with significantly less weight gain than insulin alone.

■ Metformin may be used with GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors.

■ GLP-1 receptor agonists and SGLT-2 inhibitors have synergistic mechanisms of action that help mitigate the adverse metabolic effects of one another.

■ The anti-obesity drugs phentermine/topiramate ER, orlistat, and lorcaserin can help patients reduce body weight by 5% when coupled with lifestyle modifications.

■ Clinicians need to individualize glycemic control targets with consideration of the patient’s age, comorbidities, preferences, and long-term goals.

Patients who repeatedly fail to improve glycemic control and weight may ultimately become candidates for bariatric surgery, which is the most promising treatment modality for diabesity.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
Related Content
Advertisement
Pregnant woman eating fresh vegetable salad, sitting on a sofa, healthy pregnancy concept - Image credit: Anna | stock.adobe.com
July 10th 2025

Maternal Pro-Inflammatory Diet During Pregnancy Linked to Increased Type 1 Diabetes Risk in Offspring

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic
March 13th 2024

Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic

Ashley Gallagher, Editor
Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes
July 1st 2025

Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Dina Alsalih, PharmD, PhD, MBA
Pharmacy Focus: Turning the Tide On Obesity - Episode 2
September 13th 2023

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

Diabetes - Image credit: Sherry Young | stock.adobe.com
June 27th 2025

Condition Watch: Diabetes

Kennedy Ferruggia, Assistant Editor Aislinn Antrim, Managing Editor Huiqiao (Melinda) Fan, BSc
Vials and syringe on white table with background windows - Image credit: Davizro Photography | stock.adobe.com
June 27th 2025

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Pregnant woman eating fresh vegetable salad, sitting on a sofa, healthy pregnancy concept - Image credit: Anna | stock.adobe.com
July 10th 2025

Maternal Pro-Inflammatory Diet During Pregnancy Linked to Increased Type 1 Diabetes Risk in Offspring

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic
March 13th 2024

Pharmacy Focus: Limited Series: Celebrity Endorsements in Ozempic

Ashley Gallagher, Editor
Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes
July 1st 2025

Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Dina Alsalih, PharmD, PhD, MBA
Pharmacy Focus: Turning the Tide On Obesity - Episode 2
September 13th 2023

Pharmacy Focus: Turning the Tide On Obesity - Episode 2

Diabetes - Image credit: Sherry Young | stock.adobe.com
June 27th 2025

Condition Watch: Diabetes

Kennedy Ferruggia, Assistant Editor Aislinn Antrim, Managing Editor Huiqiao (Melinda) Fan, BSc
Vials and syringe on white table with background windows - Image credit: Davizro Photography | stock.adobe.com
June 27th 2025

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.